Drug Shortage Report for BIO-ROSUVASTATIN
| Report ID | 131512 |
| Drug Identification Number | 02444992 |
| Brand name | BIO-ROSUVASTATIN |
| Common or Proper name | ROSUVASTATIN |
| Company Name | BIOMED PHARMA |
| Market Status | MARKETED |
| Active Ingredient(s) | ROSUVASTATIN |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2021-01-13 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2021-01-14 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2021-01-14 | English | Compare |
| v2 | 2021-01-13 | French | Compare |
| v1 | 2021-01-13 | English | Compare |